{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:09:43Z","timestamp":1790683783970,"version":"4.1.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,18]]},"DOI":"10.7759\/cureus.75947","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T14:55:21Z","timestamp":1734533721000},"source":"Crossref","is-referenced-by-count":1,"title":["A Case of Eltrombopag-Induced Thrombotic Microangiopathy Initiating Hemodialysis"],"prefix":"10.7759","author":[{"given":"Haruka","family":"Fukuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mineaki","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Sawase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Tsushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Irie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisuke","family":"Katafuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Mukae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/srep39003","article-title":"Efficacy and safety of thrombopoietin receptor agonists in patients with primary immune thrombocytopenia: a systematic review and meta-analysis","volume":"6","author":"Wang L","year":"2016","unstructured":"Wang L, Gao Z, Chen XP, et al.. Efficacy and safety of thrombopoietin receptor agonists in patients with primary immune thrombocytopenia: a systematic review and meta-analysis. Sci Rep. 2016, 6:39003. 10.1038\/srep39003","journal-title":"Sci Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1177\/1076029616663849","article-title":"Tolerability and efficacy of eltrombopag in chronic immune thrombocytopenia: meta-analysis of randomized controlled trials","volume":"23","author":"Elgebaly AS","year":"2017","unstructured":"Elgebaly AS, Ashal GE, Elfil M, Menshawy A. Tolerability and efficacy of eltrombopag in chronic immune thrombocytopenia: meta-analysis of randomized controlled trials. Clin Appl Thromb Hemost. 2017, 23:928-937. 10.1177\/1076029616663849","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1615856","article-title":"Thrombopoietin-induced signal transduction and potentiation of platelet activation","volume":"82","author":"Oda A","year":"1999","unstructured":"Oda A, Miyakawa Y, Druker BJ, et al.. Thrombopoietin-induced signal transduction and potentiation of platelet activation. Thromb Haemost. 1999, 82:377-384. 10.1055\/s-0037-1615856","journal-title":"Thromb Haemost"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60959-2","article-title":"Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study","volume":"377","author":"Cheng G","year":"2011","unstructured":"Cheng G, Saleh MN, Marcher C, et al.. Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study. Lancet. 2011, 377:393-402. 10.1016\/S0140-6736(10)60959-2","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis S","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T, et al.. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006, 4:295-306. 10.1111\/j.1538-7836.2006.01753.x","journal-title":"J Thromb Haemost"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21789","article-title":"Acute renal failure in a patient with antiphospholipid syndrome and immune thrombocytopenic purpura treated with eltrombopag","volume":"85","author":"Sperati CJ","year":"2010","unstructured":"Sperati CJ, Streiff MB. Acute renal failure in a patient with antiphospholipid syndrome and immune thrombocytopenic purpura treated with eltrombopag. Am J Hematol. 2010, 85:724-726. 10.1002\/ajh.21789","journal-title":"Am J Hematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1112230","article-title":"Thrombopoietin-receptor agonists for immune thrombocytopenia","volume":"365","author":"Jansen AJ","year":"2011","unstructured":"Jansen AJ, Swart RM, te Boekhorst PA. Thrombopoietin-receptor agonists for immune thrombocytopenia. N Engl J Med. 2011, 365:2240-2241. 10.1056\/NEJMc1112230","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(96)90389-3","article-title":"Focal segmental glomerulosclerosis with acute renal failure associated with alpha-interferon therapy","volume":"28","author":"Coroneos E","year":"1996","unstructured":"Coroneos E, Petrusevska G, Varghese F, Truong LD. Focal segmental glomerulosclerosis with acute renal failure associated with alpha-interferon therapy. Am J Kidney Dis. 1996, 28:888-892. 10.1016\/S0272-6386(96)90389-3","journal-title":"Am J Kidney Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-241462","article-title":"Acute kidney injury and nephrotic syndrome associated with eltrombopag therapy in chronic idiopathic thrombocytopenic purpura","volume":"14","author":"Ghosh SA","year":"2021","unstructured":"Ghosh SA, Patrick J, Maw KZ. Acute kidney injury and nephrotic syndrome associated with eltrombopag therapy in chronic idiopathic thrombocytopenic purpura. BMJ Case Rep. 2021, 14:e241462. 10.1136\/bcr-2020-241462","journal-title":"BMJ Case Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.12890\/2024_004564","article-title":"Acute renal thrombotic microangiopathy caused by eltrombopag and romiplostim in a patient with myelodysplastic syndromes (MDS) and underlying antiphospholipid syndrome","volume":"11","author":"Sood N","year":"2024","unstructured":"Sood N, Kushnir M, Jayavelu B. Acute renal thrombotic microangiopathy caused by eltrombopag and romiplostim in a patient with myelodysplastic syndromes (MDS) and underlying antiphospholipid syndrome. Eur J Case Rep Intern Med. 2024, 11:004564. 10.12890\/2024_004564","journal-title":"Eur J Case Rep Intern Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/nep.13799","article-title":"A case report of eltrombopag associated renal limited thrombotic microangiopathy leading to acute renal failure managed with plasma exchange","volume":"25","author":"Bali P","year":"2020","unstructured":"Bali P, Hidayati L, Nelson C, Dow C. A case report of eltrombopag associated renal limited thrombotic microangiopathy leading to acute renal failure managed with plasma exchange. Nephrology. 2020, 25:40-82. 10.1111\/nep.13799","journal-title":"Nephrology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59091645","article-title":"Clinical care team's guide for awareness on risk assessment of eltrombopag complicating acute kidney injury in relapsed immune thrombocytopenic patients: a case report","volume":"59","author":"Hamed EM","year":"2023","unstructured":"Hamed EM, Meabed MH, Ibrahim AR, et al.. Clinical care team's guide for awareness on risk assessment of eltrombopag complicating acute kidney injury in relapsed immune thrombocytopenic patients: a case report. Medicina (Kaunas). 2023, 59:1645. 10.3390\/medicina59091645","journal-title":"Medicina (Kaunas)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2169\/naika.102.1461","article-title":"Case report; a thromboembolic event in a patient with antiphospholipid antibody associated thrombocytopenia during eltrombopag therapy [Article in Japanese]","volume":"102","author":"Kanda M","year":"2013","unstructured":"Kanda M, Kondo M, Yamamoto S, Mukai M. Case report; a thromboembolic event in a patient with antiphospholipid antibody associated thrombocytopenia during eltrombopag therapy [Article in Japanese]. Nihon Naika Gakkai Zasshi. 2013, 102:1461-1463. 10.2169\/naika.102.1461","journal-title":"Nihon Naika Gakkai Zasshi"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1088031","article-title":"Drug-induced thrombotic microangiopathy: an updated review of causative drugs, pathophysiology, and management","volume":"13","author":"Mazzierli T","year":"2022","unstructured":"Mazzierli T, Allegretta F, Maffini E, Allinovi M. Drug-induced thrombotic microangiopathy: an updated review of causative drugs, pathophysiology, and management. Front Pharmacol. 2022, 13:1088031. 10.3389\/fphar.2022.1088031","journal-title":"Front Pharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/312654-a-case-of-eltrombopag-induced-thrombotic-microangiopathy-initiating-hemodialysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T14:55:23Z","timestamp":1734533723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/312654-a-case-of-eltrombopag-induced-thrombotic-microangiopathy-initiating-hemodialysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.75947","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,18]]}}}